Riccardo Nevola

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon et al. · Cardiovascular Diabetology · 2021 · 126 citations · Full text

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

Salvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani et al. · Journal of Hepatology · 2018 · 117 citations · Full text

Liver Fibrosis, Hepatology, Hepatitis C +13

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact

Alfredo Caturano, Carlo Acierno, Riccardo Nevola et al. · Processes · 2021 · 102 citations · Full text

Metabolic Disorder, Pathology, Fatty Liver Disease +22

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani et al. · Atherosclerosis · 2020 · 95 citations

Viral Persistence, Hepatology, Cardiovascular Disease +13

Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients

Luigi Elio Adinolfi, Riccardo Nevola, Barbara Guerrera et al. · Journal of Gastroenterology and Hepatology · 2017 · 90 citations